bovin
major
caus
respiratori
tract
diseas
cattl
vaccin
cattl
high
prioriti
major
concern
current
modifi
live
vaccin
abil
caus
latent
infect
subsequ
reactiv
result
mani
outbreak
thu
need
altern
strategi
gener
two
recombin
newcastl
diseas
virus
ndv
express
glycoprotein
gd
ad
gene
one
recombin
rlasotagdfl
express
gd
without
modif
recombin
rlasotagdf
express
chimer
gd
ectodomain
gd
fuse
transmembran
domain
cytoplasm
tail
ndv
fusion
f
glycoprotein
remark
nativ
gd
express
rlasotagdfl
viru
incorpor
ndv
virion
effici
nativ
ndv
protein
wherea
chimer
gd
detect
incorpor
even
though
abundantli
express
infect
cell
surfac
express
gd
increas
virul
rndv
vector
chicken
singl
intranas
intratrach
inocul
calv
either
recombin
ndv
elicit
mucos
system
antibodi
specif
respons
rlasotagdfl
higher
rlasotagdf
follow
challeng
calv
immun
recombin
ndv
lower
titer
earlier
clearanc
challeng
viru
compar
empti
vector
control
reduc
diseas
observ
rlasotagdfl
follow
challeng
titer
serum
antibodi
specif
higher
anim
immun
rndv
vaccin
compar
rndv
parent
viru
indic
vaccin
prime
secondari
respons
data
suggest
ndv
use
vaccin
vector
bovin
gd
may
use
mucos
vaccin
infect
might
requir
augment
second
dose
inclus
addit
antigen
bovin
pathogen
major
econom
import
cattl
industri
worldwid
caus
agent
respiratori
infect
infecti
bovin
rhinotrach
genit
infect
infecti
pustular
vulvovagin
conjunct
system
infect
lead
abort
fetal
death
furthermor
associ
meningoencephalit
diseas
infecti
balanoposth
may
predispos
cattl
secondari
opportunist
bacteri
infect
current
use
vaccin
formul
either
inactiv
modifi
live
viru
number
disadvantag
inactiv
vaccin
usual
poor
immunogen
may
caus
clinic
disthat
gd
subunit
vaccin
prepar
use
recombin
baculoviru
tobacco
mosaic
viru
gd
express
adenoviru
vector
provid
partial
protect
reduc
viru
shed
howev
effort
translat
practic
use
due
limit
effect
deliveri
vaccin
antigen
mucos
surfac
incomplet
protect
therefor
need
evalu
addit
viral
vector
deliv
antigen
cattl
last
year
revers
genet
system
mani
nonseg
negativestrand
rna
virus
nnsv
develop
studi
pathogenesi
biolog
virus
also
engin
vaccin
vector
among
newcastl
diseas
viru
ndv
particular
interest
candid
vaccin
vector
deliveri
foreign
antigen
ndv
member
genu
avulaviru
famili
paramyxovirida
genom
ndv
singlestrand
negativesens
rna
contain
six
gene
order
encod
eight
protein
ndv
caus
econom
import
diseas
affect
speci
bird
sever
diseas
avian
speci
depend
pathotyp
ndv
strain
host
speci
lentogen
strain
caus
mild
asymptomat
infect
restrict
respiratori
tract
mesogen
strain
intermedi
virul
velogen
strain
caus
system
infect
high
mortal
current
lentogen
strain
wide
use
live
ndv
vaccin
poultri
throughout
world
ndv
sever
properti
use
vaccin
vector
nonavian
host
ndv
attenu
nonhuman
primat
like
nonavian
speci
due
natur
host
rang
restrict
ndv
antigen
distinct
common
anim
human
pathogen
thu
would
affect
preexist
immun
human
anim
ndv
infect
effici
via
intranas
rout
shown
induc
humor
cellular
immun
respons
mucos
system
level
murin
nonhuman
primat
model
ndv
use
express
protect
antigen
simian
immunodefici
viru
respiratori
syncyti
viru
avian
influenza
viru
human
immunodefici
viru
mice
human
parainfluenza
viru
type
sever
acut
respiratori
syndrom
associ
coronaviru
avian
influenza
viru
monkey
howev
ndv
explor
viral
vector
pathogen
cattl
mani
diseas
cattl
effect
vaccin
avail
recent
evalu
replic
immunogen
ndv
calv
show
ndv
highli
attenu
due
host
rang
restrict
yet
induc
virusspecif
humor
mucos
antibodi
respons
unnatur
host
present
studi
examin
wide
use
avirul
ndv
vaccin
strain
lasota
topic
respiratori
vaccin
vector
deliv
gd
test
foreign
antigen
two
differ
recombin
ndv
one
express
nativ
gd
express
chimer
version
gd
construct
ndv
vector
vaccin
evalu
replic
pathogen
bird
immunogen
protect
follow
intratrach
immun
calv
result
indic
singl
administr
recombin
ndv
express
gd
result
induct
mucos
system
antibodi
respons
provid
partial
protect
challeng
virul
ndv
vector
vaccin
safe
attenu
cattl
suggest
ndv
use
elicit
antigen
specif
immun
respons
pathogen
cattl
data
indic
gd
alon
may
suffici
confer
complet
protect
challeng
inclus
glycoprotein
name
gc
gb
along
gd
may
necessari
gener
complet
protect
madindarbi
bovin
kidney
mdbk
human
epidermoid
carcinoma
chicken
embryo
fibroblast
cell
line
obtain
american
type
cultur
collect
atcc
manassa
va
cell
grown
dulbecco
modifi
eagl
medium
dmem
contain
fetal
bovin
serum
fb
maintain
dmem
fb
mdbk
cell
grown
eagl
minimum
essenti
medium
emem
contain
hors
serum
maintain
emem
hors
serum
recombin
wildtyp
ndv
strain
grown
specificpathogenfre
spf
embryon
chicken
egg
strain
cooper
obtain
atcc
propag
mdbk
cell
modifi
vaccinia
viru
strain
ankara
express
rna
polymeras
grown
primari
chicken
embryo
fibroblast
cell
construct
plasmid
plasota
carri
fulllength
antigenom
cdna
lentogen
ndv
vaccin
strain
lasota
describ
previous
two
version
gd
gene
construct
insert
ndv
genom
genom
dna
isol
purifi
use
standard
protocol
make
insert
encod
unmodifi
gd
glycoprotein
gd
open
read
frame
orf
genom
dna
amplifi
pcr
use
forward
primer
revers
primer
introduc
pmei
site
italic
ndv
gene
end
gene
start
transcript
signal
underlin
intergen
nucleotid
boldfac
addit
nucleotid
order
maintain
genom
length
multipl
six
italic
bold
sixnucleotid
kozak
sequenc
effici
translat
bold
underlin
sequenc
small
case
pcr
perform
use
ng
predenatur
viral
dna
pmol
primer
gc
buffer
contain
mg
dntp
unit
takara
la
taq
tm
polymeras
takara
bio
usa
madison
wi
amplif
base
pair
product
digest
pmei
clone
pcr
vector
invitrogen
integr
gd
gene
confirm
sequenc
analysi
second
version
gd
gene
construct
ectodomain
gd
fuse
transmembran
domain
cytoplasm
tail
amino
acid
ndv
f
protein
overlap
pcr
briefli
gd
gene
amplifi
pcr
use
forward
primer
describ
revers
primer
pmei
site
italic
sequenc
specif
gd
gene
posit
lowercas
amplifi
transmembran
domain
cytoplasm
tail
sequenc
ndv
f
gene
pcr
perform
use
forward
primer
sequenc
specif
gd
gene
overlap
lower
case
ndv
f
gene
transmembranespecif
sequenc
uppercas
revers
primer
pmei
site
italic
ndv
f
gene
cytoplasm
tailspecif
sequenc
uppercas
fragment
ligat
overlap
pcr
use
forward
primer
revers
primer
amplif
pcr
product
digest
pmei
clone
pcr
vector
integr
gd
gene
confirm
sequenc
analysi
insert
bear
gd
gene
releas
digest
pmei
dephosphoryl
insert
uniqu
pmei
site
p
gene
fulllength
ndv
plasmid
plasmid
contain
nativ
gd
orf
gd
ectodomain
fuse
ndv
transmembran
domain
cytoplasm
tail
design
plasotagdfl
plasotagdf
respect
recombin
virus
recov
plasotagdfl
plasotagdf
antigenom
cdna
follow
procedur
describ
previous
recov
recombin
virus
design
rlasotagdfl
rlasotagdf
respect
recombin
virus
plaqu
purifi
grown
embryon
spf
chicken
egg
gd
gene
genom
rna
purifi
virus
amplifi
rtpcr
sequenc
analyz
confirm
correct
gd
gene
structur
absenc
adventiti
mutat
express
gd
recombin
virus
examin
cell
immunofluoresc
assay
briefli
confluent
monolay
cell
labtek
chamber
slide
infect
recombin
virus
multipl
infect
moi
h
infect
control
cell
wash
phosphat
buffer
salin
pb
either
fix
paraformaldehyd
min
room
temperatur
detect
surfac
antigen
fix
paraformaldehyd
min
room
temperatur
permeabil
triton
pb
min
detect
total
antigen
wash
pb
cell
incub
min
normal
goat
serum
block
nonspecif
bind
site
incub
h
dilut
pool
gd
specif
monoclon
antibodi
kindli
provid
dr
suresh
k
tikoo
vaccin
infecti
diseas
organ
saskatoon
canada
cell
rins
pb
incub
dilut
alexa
fluor
conjug
goat
antimous
immunoglobulin
g
antibodi
invitrogen
carlsbad
ca
min
cell
wash
pb
analyz
fluoresc
microscop
confirm
express
gd
recombin
virus
flow
cytometri
assay
perform
briefli
cell
tissu
cultur
flask
infect
recombin
viru
moi
h
cell
detach
pb
contain
mm
edta
centrifug
g
min
c
cell
pellet
resuspend
ca
mg
defici
pb
supplement
normal
goat
serum
cell
incub
gd
specif
monoclon
antibodi
dilut
min
c
subsequ
cell
wash
pb
incub
min
ice
dilut
alexa
fluor
conjug
goat
anti
mous
immunoglobulin
g
antibodi
cell
analyz
use
facsria
ii
apparatu
flowjo
softwar
becton
dickinson
bioscienc
examin
incorpor
nativ
chimer
gd
ndv
virion
spf
embryon
egg
infect
rndv
allanto
fluid
harvest
h
postinfect
allanto
fluid
clarifi
lowspe
centrifug
virus
concentr
ultracentrifug
wv
sucros
pb
g
c
h
resuspend
pb
viral
protein
purifi
viru
prepar
analyz
sdspage
follow
coomassi
blue
stain
pathogen
recombin
virus
chicken
determin
two
internationallyestablish
vivo
test
mean
death
time
mdt
test
spf
embryon
chicken
egg
intracerebr
pathogen
index
icpi
test
spf
chicken
mdt
test
perform
standard
procedur
briefli
seri
dilut
fresh
allanto
fluid
egg
infect
test
viru
made
steril
pb
ml
dilut
inocul
allanto
caviti
five
embryon
chicken
egg
egg
incub
c
examin
four
time
daili
day
time
embryo
first
observ
dead
record
highest
dilut
kill
embryo
consid
minimum
lethal
dose
mdt
record
time
h
minimum
lethal
dose
kill
embryo
mdt
use
classifi
ndv
strain
velogen
take
h
kill
mesogen
take
h
kill
lentogen
take
h
kill
icpi
test
perform
describ
previous
briefli
fresh
allanto
fluid
egg
infect
test
viru
dilut
inocul
group
ten
spf
chick
via
intracerebr
rout
inocul
done
use
needl
attach
stepper
syring
dispens
set
dispens
ml
inoculum
per
inocul
bird
observ
daili
day
observ
bird
score
normal
sick
dead
icpi
valu
mean
score
per
bird
per
observ
highli
virul
virus
give
valu
approach
avirul
virus
give
valu
approach
gdspecif
immun
respons
recombin
virus
examin
spf
white
leghorn
chicken
spafa
norwich
ct
chicken
inocul
l
fresh
allanto
fluid
contain
rlasota
rlasotagdfl
rlasotagdf
viru
hemagglutin
titer
oculonas
rout
chicken
observ
daili
nasal
discharg
respiratori
symptom
weight
loss
week
postimmun
blood
sampl
collect
start
experi
end
week
serum
sampl
assess
antibodi
respons
ndv
hemagglutin
test
gd
western
blot
analysi
lysat
purifi
neutral
abil
chicken
antiserum
determin
plaqu
reduct
neutral
assay
immunogen
protect
efficaci
recombin
virus
evalu
holsteinfriesian
calv
confirm
seroneg
elisa
ndv
hi
assay
calv
hous
isol
stall
usdaapprov
aaalaccertifi
facil
thoma
morri
inc
reistertown
md
usa
anim
care
accord
protocol
approv
anim
care
use
committe
thoma
morri
inc
strict
biosecur
measur
observ
throughout
experiment
period
nine
week
old
calv
randomli
divid
group
three
immun
rlasota
rlasotagdfl
rlasotagdf
viru
calv
infect
singl
dose
recombin
viru
pfuml
combin
ml
nostril
ml
rout
initi
studi
found
method
appropri
infect
calv
ndv
calv
challeng
ml
nostril
virul
strain
cooper
day
immun
euthan
day
postchalleng
calv
clinic
evalu
daili
veterinarian
end
studi
gener
appear
rectal
temperatur
inappet
nasal
discharg
conjunct
abnorm
lung
sound
cough
sneez
calv
bled
day
follow
immun
analysi
antibodi
respons
serum
assess
shed
vaccin
challeng
virus
nasal
swab
collect
day
day
respect
store
antibiot
solut
c
nasal
swab
use
ndv
isol
titrat
nasal
secret
collect
day
day
describ
previous
briefli
slenders
tampon
insert
one
nostril
approxim
min
secret
harvest
centrifug
snap
frozen
c
analyz
later
mucos
antibodi
respons
day
postchalleng
anim
sacrif
examin
gross
patholog
lesion
isol
titrat
ndv
nasal
swab
carri
spf
embryon
chicken
egg
briefli
l
eluent
nasal
swab
inocul
allanto
cavitiy
egg
allanto
fluid
harvest
h
postinocul
check
ndv
growth
hemagglutin
ha
assay
isol
titrat
nasal
swab
perform
plaqu
assay
mdbk
cell
plate
methyl
cellulos
overlay
titer
standard
use
equal
amount
nasal
swab
eluent
l
anim
hemagglutin
inhibit
hi
assay
perform
measur
ndvspecif
antibodi
respons
describ
previous
hi
assay
chicken
erythrocyt
wild
type
ndv
strain
lasota
use
indic
viru
serial
dilut
heat
inactiv
c
min
calf
sera
use
inhibit
ha
unit
viru
antibodi
respons
calf
sera
determin
western
blot
analysi
mdbk
cell
infect
moi
pfu
per
cell
overli
medium
harvest
h
infect
particl
purifi
harvest
medium
sucros
gradient
centrifug
purifi
separ
sdspage
gel
blot
nitrocellulos
membran
incub
overnight
dilut
buffer
synbiot
kansa
citi
mo
next
day
membran
incub
h
room
temperatur
calf
sera
dilut
dilut
buffer
membran
wash
wash
solut
synbiot
kansa
citi
mo
four
time
incub
dilut
hrp
conjug
goat
antibovin
igg
kpl
gaithersburg
md
h
room
temperatur
wash
four
time
gdspecif
protein
detect
use
chemiluminesc
assay
kit
ge
healthcar
neutral
antibodi
calf
sera
measur
plaqu
reduct
neutral
assay
mdbk
cell
serial
dilut
heat
inactiv
calf
sera
mix
pfu
incub
h
c
residu
infecti
viru
serumviru
mixtur
quantifi
plaqu
assay
mdbk
cell
titer
express
reciproc
highest
dilut
serum
reduc
plaqu
number
specif
igg
iga
respons
measur
serum
nasal
secret
respect
elisa
use
serelisa
total
ab
mono
indirect
kit
synbiot
corpor
lyon
cedex
franc
briefli
dilut
day
dilut
day
bovin
sera
dilut
nasal
secret
incub
duplic
viral
antigen
coat
plate
h
c
bound
antibodi
detect
use
horseradish
peroxidaseconjug
antibovin
igg
antibodi
kirkgaard
perri
lab
igg
iga
titr
serum
sampl
nasal
secret
express
sampl
posit
sp
ratio
sp
ratio
calcul
subtract
averag
normal
control
absorb
sampl
absorb
divid
differ
correct
posit
control
differ
averag
posit
absorb
averag
normal
control
absorb
accord
manufactur
protocol
sampl
consid
posit
antibodi
sp
ratio
recombin
lentogen
ndv
strain
lasota
contain
uniqu
pmei
site
p
gene
use
vector
express
gd
glycoprotein
ad
gene
gd
gene
amplifi
pcr
genom
dna
extract
purifi
virion
gd
orf
place
control
ndv
transcript
signal
insert
pmei
site
p
gene
ndv
vector
fig
transcript
cassett
design
maintain
rule
six
wherebi
genom
nucleotid
length
must
even
multipl
six
order
effici
replic
kozak
sequenc
insert
start
codon
gd
gene
orf
provid
effici
translat
result
plasmid
design
plasotagdfl
encod
antigenom
nt
increas
nt
compar
parent
ndv
strain
lasota
potenti
strategi
increas
effici
incorpor
gd
ndv
vector
virion
made
anoth
construct
ectodomain
gd
fuse
transmembran
domain
cytoplasm
tail
ndv
f
protein
chimer
gene
flank
ndv
transcript
signal
insert
ndv
antigenom
cdna
way
describ
fig
result
plasmid
design
plasotagdf
encod
antigenom
nt
length
plasotagdfl
also
conform
rule
six
recombin
virus
design
rlasotagdfl
rlasotagdf
recov
use
revers
genet
method
describ
previous
structur
gd
insert
genom
virus
confirm
rtpcr
nucleotid
sequenc
analysi
data
shown
recombin
virus
propag
embryon
chicken
egg
titer
determin
ha
assay
ha
titer
rlasotagdfl
rlasotagdf
virus
log
lower
parent
rlasota
viru
result
consist
previou
find
moder
attenu
replic
result
insert
foreign
gene
determin
stabil
gd
gene
rlasotagdfl
rlasotagdf
virus
recov
virus
passag
five
time
embryon
chicken
egg
five
time
chicken
embryo
fibroblast
cell
sequenc
analysi
gd
gene
result
viru
prepar
show
integr
gd
gene
preserv
stabli
maintain
even
passag
express
two
version
gd
mdbk
cell
infect
rlasotagdfl
rlasotagdf
virus
analyz
indirect
immunofluoresc
use
pool
gdspecif
monoclon
antibodi
intracellular
express
investig
cell
fix
permeabil
triton
deterg
show
gd
express
effici
cytoplasm
cell
line
rlasotagdfl
rlasotagdf
virus
h
postinfect
fig
panel
b
c
e
f
abl
perform
western
blot
analysi
gd
specif
monoclon
antibodi
antibodi
recogn
conform
depend
epitop
visual
cell
surfac
express
gd
infect
mdbk
cell
fix
paraformaldehyd
incub
gdspecif
monoclon
antibodi
follow
immunostain
alexa
fluorconjug
goat
antimous
igg
antibodi
shown
fig
extens
express
gd
surfac
cell
type
infect
rlasotagdfl
rlasotagdf
virus
panel
b
c
e
f
fluoresc
stain
observ
mononoclon
antibodi
specif
gd
sinc
reactiv
observ
surfac
cell
infect
rlasota
viru
panel
express
gd
surfac
cell
infect
recombin
virus
examin
quantit
flow
cytometri
analysi
infect
cell
cell
treat
gdspecif
monoclon
antibodi
follow
stain
alexa
fluor
conjug
goat
anti
mous
igg
antibodi
analyz
flow
cytometri
fluoresc
histogram
cell
infect
rlasotagdfl
rlasotagdf
rlasota
virus
shown
fig
cell
infect
rlasotagdfl
viru
show
higher
level
express
compar
rlasotagdf
viru
rlasotagdfl
rlasotagdf
report
express
foreign
envelop
glycoprotein
recombin
nnsv
result
incorpor
protein
virion
variou
effici
moreov
shown
replac
transmembran
domain
cytoplasm
tail
foreign
envelop
protein
ndv
envelop
protein
increas
incorpor
foreign
glycoprotein
ndv
virion
therefor
want
determin
whether
nativ
chimer
gd
incorpor
ndv
virion
recombin
virus
purifi
sucros
gradient
viral
protein
analyz
coomassi
blue
stain
sdspage
gel
surprisingli
nativ
gd
express
rlasotagdfl
rather
chimer
gd
express
rlasotagdf
incorpor
virion
fig
monomer
kda
dimer
kda
form
nativ
gd
detect
coomassi
blue
stain
incomplet
dissoci
gd
homoligom
sdspage
commonli
observ
chimer
gd
express
rlasotagdf
visibl
coomassi
blue
stain
indic
either
chimer
gd
incorpor
small
amount
detect
level
incorpor
densitometr
analysi
gel
indic
rel
molar
amount
nativ
gd
incorpor
ndv
virion
approxim
greater
ndv
hn
protein
quantif
ndv
np
p
f
hn
l
protein
band
show
molar
ratio
protein
remain
unaffect
rlasotagdf
rlasotagdfl
virus
compar
parent
rlasota
viru
data
shown
result
suggest
transmembran
domain
gd
highli
effici
direct
incorpor
heterolog
ndv
envelop
foreign
gd
appear
displac
nativ
ndv
protein
pathogen
rlasotagdfl
rlasotagdf
virus
along
parent
rlasota
viru
determin
embryon
chicken
egg
mdt
test
ndv
strain
categor
three
pathotyp
basi
mdt
valu
velogen
less
h
mesogen
h
lentogen
greater
h
valu
mdt
rlasota
rlasotagdfl
rlasotagdf
respect
tabl
also
evalu
pathogen
recombin
virus
chick
icpi
test
velogen
strain
give
valu
approach
wherea
lentogen
strain
give
valu
close
icpi
valu
rlasota
rlasotagdfl
rlasotagdf
tabl
test
indic
incorpor
version
gd
ndv
virion
increas
pathogen
recombin
virus
chicken
inde
mdt
test
suggest
presenc
ad
nativ
chimer
gd
gene
confer
small
amount
addit
attenu
ndv
vector
abil
rlasotagdfl
rlasotagdf
virus
induc
serum
antibodi
vector
foreign
gd
protein
evalu
chicken
twoweekold
chicken
inocul
rlasota
rlasotagdfl
rlasotagdf
viru
oculonas
rout
induct
ndvspecif
antibodi
measur
hi
assay
ndv
hi
titer
rang
log
log
observ
chicken
inocul
rlasota
rlasotagdfl
rlasotagdf
virus
tabl
induct
gdspecif
antibodi
determin
western
blot
hemagglutin
inhibit
titer
b
neutral
titer
c
rlasota
reduct
rlasotagdfl
rlasotagdf
valu
mean
chicken
per
group
chicken
group
inocul
l
infectedegg
allanto
fluid
serum
sampl
collect
inocul
day
follow
inocul
b
hemagglutin
inhibit
hi
titer
express
reciproc
highest
serum
dilut
caus
complet
inhibit
four
ha
unit
ndv
c
neutral
titer
determin
plaqu
reduct
assay
mdbk
cell
serum
dilut
give
plaqu
reduct
consid
neutral
end
point
analysi
purifi
protein
plaqu
reduct
assay
western
blot
fig
antibodi
reactiv
kda
gd
detect
sera
chicken
inocul
rlasotagdfl
rlasotagdf
virus
absent
sera
chicken
inocul
rlasota
viru
fig
densitometr
analysi
western
blot
indic
antibodi
gd
sera
chicken
immun
rlasotagdfl
viru
sera
chicken
immun
rlasotagdf
viru
result
indic
titer
gdspecif
antibodi
induc
rlasotagdfl
viru
higher
induc
rlasotagdf
viru
abil
chicken
sera
neutral
examin
plaqu
reduct
neutral
assay
tabl
chicken
inocul
rlasotagdfl
viru
develop
higher
neutral
antibodi
titer
compar
inocul
rlasotagdf
viru
rndv
express
nativ
chimer
gd
evalu
calv
safeti
replic
immunogen
protect
efficaci
nine
week
old
calv
seroneg
ndv
randomli
divid
group
three
group
immun
singl
dose
pfu
rlasota
rlasotagdfl
rlasotagdf
viru
combin
rout
calv
observ
daili
day
postinfect
clinic
sign
diseas
none
anim
show
clinic
diseas
sign
follow
inocul
recombin
ndv
nasal
swab
collect
day
fig
western
blot
detect
gdspecif
antibodi
sera
chicken
follow
inocul
ndv
recombin
oculonas
rout
grown
cell
cultur
purifi
sucros
gradient
centrifug
subject
sdspage
reduc
condit
transfer
nitrocellulos
cut
strip
incub
dilut
sera
repres
chicken
inocul
describ
text
tabl
rlasota
b
rlasotagdfl
c
rlasotagdf
virus
posit
gd
monom
kda
indic
arrow
right
margin
postinfect
assess
shed
ndv
vector
analysi
nasal
swab
presenc
ndv
perform
inocul
eluent
nasal
swab
embryon
chicken
egg
allanto
fluid
harvest
h
postinocul
test
ndv
replic
ha
test
evid
ndv
shed
viru
isol
nasal
swab
anim
data
shown
result
indic
ndv
highli
attenu
replic
respiratori
tract
calv
furthermor
lack
shed
mean
vaccin
viru
significantli
releas
environ
serum
antibodi
respons
calv
inocul
rndv
describ
previou
section
measur
ndvspecif
hi
assay
detect
antibodi
ndv
sera
calv
inocul
day
would
expect
singl
dose
rndv
calv
develop
ndvspecif
serum
antibodi
measur
ndv
hi
test
tabl
ndvspecif
antibodi
first
detect
day
postimmun
pi
six
calv
day
one
calf
day
remain
two
calv
respons
maxim
day
rang
except
one
calf
develop
high
hi
titer
result
suggest
ndv
vector
replic
respiratori
tract
calv
lead
induct
antibodi
ndv
result
agreement
result
previou
studi
mucos
iga
system
igg
antibodi
direct
gd
measur
commerci
elisa
kit
use
purifi
antigen
result
show
calv
immun
rlasotagdfl
rlasotagdf
virus
develop
specif
igg
iga
antibodi
respons
serum
nasal
secret
respect
respons
develop
anim
week
immun
peak
day
fig
b
two
calv
rlasotagdfl
vaccin
group
develop
significantli
higher
specif
igg
sp
ratio
respect
iga
sp
ratio
respons
compar
calv
rlasotagdf
group
also
confirm
specif
respons
western
blot
analysi
show
sera
two
calv
taken
day
follow
inocul
rlasotagdf
react
strongli
gd
data
shown
determin
abil
recombin
virus
induc
serum
antibodi
plaqu
reduct
neutral
assay
carri
use
sera
collect
differ
time
follow
immun
neutral
antibodi
titer
detect
two
anim
rlasotagdfl
group
day
follow
immun
anim
rlasotagdf
rlasota
group
neg
neutral
serum
antibodi
prior
challeng
tabl
day
immun
immun
calv
challeng
rout
high
dose
virul
strain
cooper
pfu
per
anim
follow
challeng
calv
clinic
evalu
temperatur
sever
nasal
lesion
mean
rectal
temperatur
calv
group
show
sharp
increas
three
day
challeng
fig
howev
group
vaccin
rlasotagdfl
viru
temperatur
two
calv
return
normal
fifth
day
postchalleng
two
calv
detect
bhv
fig
induct
mucos
serum
antibodi
specif
gd
follow
immun
calv
recombin
ndv
calv
group
immun
rlasota
rlasotagdf
rlasotagdfl
viru
calv
belong
rlasota
control
group
belong
rlasotagdf
group
belong
rlasotagdfl
group
specif
serum
igg
titer
b
specif
iga
titer
sp
ratio
calcul
subtract
averag
normal
control
absorb
sampl
absorb
divid
differ
correct
posit
control
differ
averag
posit
absorb
averag
normal
control
absorb
accord
manufactur
protocol
sampl
consid
posit
antibodi
sp
ratio
tabl
contrast
anim
group
immun
rlasota
rlasotagdf
maintain
increas
temperatur
period
eight
day
fig
addit
wherea
challeng
calv
develop
nasal
lesion
characterist
calv
rlasotagdfl
group
smaller
anim
data
shown
fig
mean
rectal
temperatur
rndvimmun
calv
challeng
strain
copper
calv
group
immun
rlasota
rlasotagdf
rlasotagdfl
viru
challeng
day
pfucalf
strain
cooper
calv
belong
rlasota
control
group
belong
rlasotagdf
group
belong
rlasotagdfl
group
serum
antibodi
respons
indic
ndv
vector
immun
calv
calf
postimmun
hi
antibodi
titer
b
day
day
day
day
day
day
rlasota
rlasotagdfl
rlasotagdf
calv
group
immun
combin
rout
singl
dose
pfu
rlasota
rlasotagdfl
rlasotagdf
viru
sera
collect
prior
inocul
day
indic
day
postinocul
b
hemagglutin
inhibit
hi
titer
express
reciproc
highest
serum
dilut
caus
complet
inhibit
four
ha
unit
ndv
calv
receiv
singl
init
immun
indic
rndv
describ
tabl
challeng
day
b
sera
taken
indic
day
postimmun
neutral
titer
determin
plaqu
reduct
assay
data
indic
partial
protect
diseas
two
three
calv
immun
rlasotagdfl
vaccin
shed
challeng
viru
monitor
take
nasal
swab
day
day
postchalleng
infecti
quantifi
plaqu
assay
mdbk
cell
fig
control
group
immun
rlasota
peak
mean
titer
challeng
approxim
log
ml
day
shed
decreas
continu
day
last
studi
day
anim
immun
rlasotagdf
peak
mean
titer
challeng
viru
approxim
log
ml
day
decreas
log
ml
day
shed
termin
day
anim
immun
rlasotagdfl
mean
titer
challeng
viru
exceed
log
ml
shed
termin
day
data
indic
partial
restrict
challeng
calv
immun
either
rlasotagdfl
rlasotagdf
viru
suggest
protect
efficaci
rlasotagdfl
viru
greater
rlasotagdf
viru
measur
anamnest
respons
elicit
rndvimmun
calv
follow
challeng
sera
collect
follow
challeng
analyz
commerci
elisa
kit
use
purifi
virion
antigen
fig
plaqu
reduct
assay
tabl
day
postchalleng
day
postimmun
serum
igg
respons
increas
significantli
rlasotagdfl
rlasotagdf
group
compar
rlasota
group
averag
sp
ratio
rlasotagdfl
rlasotagdf
rlasota
group
respect
fig
level
igg
respons
calv
immun
rlasotagdfl
viru
higher
immun
serum
igg
respons
induc
rndvimmun
calv
day
challeng
strain
cooper
sera
analyz
commerci
elisa
kit
use
purifi
antigen
posit
respons
determin
sp
ratio
higher
describ
legend
fig
calv
belong
rlasota
control
group
belong
rlasotagdf
group
belong
rlasotagdfl
group
rlasotagdf
viru
day
postchalleng
day
postimmun
calv
immun
either
rlasotagdfl
rlasotagdf
viru
higher
level
serum
neutral
antibodi
rang
compar
control
rlasota
calv
tabl
level
serum
neutral
antibodi
two
anim
rlasotagdfl
group
time
higher
calv
control
rlasota
rlasotagdf
group
respect
tabl
differ
magnitud
secondari
respons
support
interpret
initi
immun
rlasotagdfl
immunogen
rlasotagdf
consist
better
protect
efficaci
observ
rlasotagdfl
bovin
respiratori
diseas
brd
complex
lead
caus
econom
loss
us
cattl
industri
play
major
role
brd
complex
current
safe
effect
vaccin
avail
also
mani
devast
cattl
diseas
foreign
us
foot
mouth
diseas
fmd
rinderpest
rift
valley
fever
live
vaccin
diseas
base
attenu
form
pathogen
prohibitori
diseasefre
countri
like
us
concern
introduct
live
pathogen
therefor
need
develop
altern
vaccin
strategi
foreign
anim
diseas
involv
attenu
version
pathogen
among
possibl
strategi
one
promis
use
live
viral
vector
vaccin
major
advantag
live
viral
vector
vaccin
requir
use
whole
infecti
pathogen
efficaci
liveattenu
vaccin
ndv
sever
featur
make
promis
viral
vaccin
vector
ndv
grow
high
titer
embryon
chicken
egg
cell
line
contrast
viral
vector
encod
larg
number
protein
herp
virus
pox
virus
ndv
encod
eight
protein
therefor
less
competit
immun
respons
vector
protein
express
foreign
antigen
ndv
replic
cytoplasm
integr
host
cell
dna
genet
exchang
either
rare
occur
ndv
nnsv
thu
make
stabl
vaccin
vector
ndv
infect
effici
via
rout
induc
local
iga
system
igg
antibodi
cellmedi
immun
respons
ndv
vector
avail
base
lentogen
strain
alreadi
widespread
use
live
vaccin
pose
danger
poultri
industri
ndv
avian
viru
capabl
infect
nonavian
speci
includ
cattl
ndv
attenu
nonavian
speci
due
natur
hostrang
restrict
recent
ndv
evalu
nonhuman
primat
potenti
vaccin
vector
human
use
addit
ndv
use
oncolyt
agent
bovin
papillomatosi
cattl
shown
safe
repeat
inocul
ndv
share
low
level
amino
acid
sequenc
ident
bovin
paramyxovirus
antigen
distinct
suggest
entir
bovin
popul
would
suscept
infect
ndv
vector
vaccin
thu
prior
immun
common
bovin
virus
affect
replic
immunogen
vector
recent
shown
inocul
calv
lentogen
ndv
strain
lasota
result
asymptomat
infect
respiratori
tract
induct
mucos
system
antibodi
respons
ndv
therefor
ndv
attract
vector
bovin
pathogen
vaccin
avail
need
improv
studi
first
time
evalu
potenti
ndv
vaccin
vector
bovin
use
primari
infect
occur
mucos
surfac
via
contact
aerosol
transmiss
mucos
infect
engend
mucos
antibodi
resist
primari
infect
demonstr
previous
level
protect
correl
magnitud
mucos
antibodi
respons
envelop
three
major
surfac
glycoprotein
name
gb
gc
gd
glycoprotein
respiratori
infect
requir
gd
attach
penetr
viru
cell
monoclon
antibodi
gd
prevent
infect
thu
gd
independ
neutral
antigen
nativ
recombin
gd
shown
induc
neutral
antibodi
serum
protect
challeng
previous
shown
ndv
capabl
infect
calv
respiratori
rout
induc
humor
mucos
antibodi
without
caus
symptomat
diseas
therefor
immun
ndv
vector
respiratori
rout
would
provid
direct
stimul
immun
primari
site
infect
singl
intranas
immun
calv
ndvvector
vaccin
base
avirul
lasota
strain
induc
gdspecif
igg
iga
respons
serum
nasal
secret
respect
immun
respons
produc
singl
immun
rlasotagdfl
rlasotagdf
vaccin
suffici
prevent
shed
follow
challeng
viru
titer
durat
shed
reduc
compar
control
group
increas
gdspecif
igg
vaccin
calv
suggest
gd
express
rlasotagdfl
rlasotagdf
vaccin
suffici
prime
antigen
specif
igg
present
studi
failur
provid
complet
protect
ndv
recombin
express
gd
like
due
induct
insuffici
mucos
system
immun
respons
previou
studi
also
report
vari
degre
protect
use
adenoviru
vector
iscom
genedelet
live
dna
vaccin
subunit
vaccin
could
variou
reason
partial
protect
confer
ndv
vector
vaccin
studi
first
possibl
repetit
dose
recombin
gd
vaccin
may
requir
boost
suffici
mucos
system
antibodi
respons
complet
protect
second
shown
besid
gd
gb
gc
surfac
glycoprotein
also
immunodomin
antigen
target
neutral
antibodi
major
antigen
cellular
immun
respons
henc
incomplet
protect
gener
vaccin
ndv
vector
express
gd
might
overcom
simultan
administ
ndv
vector
express
gb
gc
protein
third
experi
calv
challeng
high
dose
virul
strain
cooper
high
dose
infect
occur
natur
condit
henc
possibl
overwhelm
immun
respons
challeng
viru
exist
magnitud
mucos
system
antibodi
induc
intranas
administr
effect
ndv
recombin
name
rlasotagdfl
variabl
among
anim
group
one
calf
low
immun
respons
compar
two
calv
similar
variat
immun
respons
among
anim
vaccin
gd
gb
also
report
previous
variat
could
associ
genet
restrict
among
bred
popul
might
overcom
administr
multipl
glycoprotein
studi
demonstr
larg
quantiti
foreign
glycoprotein
incorpor
ndv
virion
without
affect
vector
replic
pathogen
amount
nativ
gd
present
virion
recombin
rlasotagdfl
time
nativ
hn
protein
contrast
chimer
gd
ectodomain
gd
fuse
transmembran
domain
cytoplasm
tail
ndv
f
protein
design
incorpor
effici
nativ
gd
incorpor
detect
maximum
level
incorpor
foreign
protein
observ
earlier
studi
recombin
vesicular
stomat
viru
vsv
express
either
influenza
viru
hemagglutinin
ha
neuraminidas
na
glycoprotein
measl
viru
h
f
protein
respiratori
syncyti
viru
f
protein
extra
gene
vsv
g
protein
exampl
ebola
viru
glycoprotein
gp
express
human
parainfluenza
viru
type
vector
incorpor
vector
particl
effici
nativ
protein
avian
influenza
viru
express
ndv
vector
incorpor
effici
nativ
protein
addit
observ
incorpor
gd
chang
molar
ratio
ndv
hn
f
protein
rel
nucleocapsid
matrix
protein
appear
affect
yield
particl
infect
result
suggest
space
constraint
incorpor
foreign
protein
envelop
ndv
present
know
basi
highli
effici
incorpor
gd
protein
ndv
virion
one
possibl
featur
amino
acid
sequenc
transmembran
domain
cytoplasm
tail
nativ
gd
make
effici
inclus
particl
anoth
possibl
gd
might
accumul
cell
surfac
higher
molar
amount
compar
ndv
protein
lead
effici
incorpor
howev
remain
unexplain
chimer
gd
protein
contain
cytoplasm
transmembran
ndv
f
protein
accumul
effici
cell
surfac
yet
significantli
incorpor
one
potenti
consequ
incorpor
high
amount
gd
viru
particl
might
lead
increas
virul
ndv
vector
observ
mdt
icpi
test
chicken
furthermor
rlasotagdfl
viru
remain
restrict
replic
bovin
lasota
empti
vector
rlasotagdf
vaccin
summari
first
time
evalu
potenti
avian
viru
vaccin
vector
bovin
use
commonli
use
ndv
vaccin
strain
lasota
use
express
gd
result
show
calv
vaccin
recombin
virus
elicit
immun
respons
gd
provid
partial
protect
challeng
result
suggest
gd
could
use
compon
mucos
vaccin
infect
vector
vaccin
candid
highli
attenu
replic
cattl
shed
environ
furthermor
observ
ndv
neglig
incid
recombin
circul
virus
cattl
popul
make
promis
safe
vaccin
deliveri
vector
candid
bovin
popul
strategi
may
use
develop
live
viral
vector
vaccin
foreign
anim
diseas
current
safe
effect
vaccin
avail
